117 related articles for article (PubMed ID: 38527286)
1. Association of State Insulin Out-of-Pocket Caps With Insulin Cost-Sharing and Use Among Commercially Insured Patients With Diabetes : A Pre-Post Study With a Control Group.
Garabedian LF; Zhang F; Costa R; Argetsinger S; Ross-Degnan D; Wharam JF
Ann Intern Med; 2024 Apr; 177(4):439-448. PubMed ID: 38527286
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps.
Dusetzina SB; Huskamp HA; Jazowski SA; Winn AN; Basch E; Keating NL
JAMA Health Forum; 2021 May; 2(5):e210673. PubMed ID: 35977314
[TBL] [Abstract][Full Text] [Related]
3. Reduced Cost-sharing for Preventive Drugs Preferentially Benefits Low-income Patients With Diabetes in High Deductible Health Plans With Health Savings Accounts.
Ross-Degnan D; Wallace J; Zhang F; Soumerai SB; Garabedian L; Wharam JF
Med Care; 2020 Jun; 58 Suppl 6 Suppl 1(Suppl 6 1):S4-S13. PubMed ID: 32412948
[TBL] [Abstract][Full Text] [Related]
4. The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.
Spargo A; Yost C; Squires P; Raju A; Schroader B; Brown JD
J Manag Care Spec Pharm; 2021 May; 27(5):554-564. PubMed ID: 33908275
[No Abstract] [Full Text] [Related]
5. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
6. Acute Diabetes Complications After Transition to a Value-Based Medication Benefit.
Wharam JF; Argetsinger S; Lakoma M; Zhang F; Ross-Degnan D
JAMA Health Forum; 2024 Feb; 5(2):e235309. PubMed ID: 38334992
[TBL] [Abstract][Full Text] [Related]
7. Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.
Yeung K; Barthold D; Dusetzina SB; Basu A
N Engl J Med; 2020 Aug; 383(6):558-566. PubMed ID: 32757524
[TBL] [Abstract][Full Text] [Related]
8. Projected Impact of the Medicare Part D Senior Savings Model on Diabetes-Related Health and Economic Outcomes Among Insulin Users Covered by Medicare.
Shao H; Guan D; Guo J; Jiao T; Zhang Y; Luo J; Shi L; Fonseca V; Brown JD
Diabetes Care; 2022 Aug; 45(8):1814-1821. PubMed ID: 35700384
[TBL] [Abstract][Full Text] [Related]
9. Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition.
Feng K; Russo M; Maini L; Kesselheim AS; Rome BN
JAMA Health Forum; 2024 Mar; 5(3):e235429. PubMed ID: 38551589
[TBL] [Abstract][Full Text] [Related]
10. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
Klepser DG; Huether JR; Handke LJ; Williams CE
J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
[TBL] [Abstract][Full Text] [Related]
11. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
[No Abstract] [Full Text] [Related]
12. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
Narang AK; Nicholas LH
JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
[TBL] [Abstract][Full Text] [Related]
13. National Trends in Out-of-Pocket Costs Among U.S. Adults With Diabetes Aged 18-64 Years: 2001-2017.
Wang Y; Park J; Li R; Luman E; Zhang P
Diabetes Care; 2021 Nov; 44(11):2510-2517. PubMed ID: 34429323
[TBL] [Abstract][Full Text] [Related]
14. Exacerbation of financial burden of insulin and overall glucose-lowing medications among uninsured population with diabetes.
Lin Y; Shao H; Fonseca V; Shi L
J Diabetes; 2023 Mar; 15(3):215-223. PubMed ID: 36751859
[TBL] [Abstract][Full Text] [Related]
15. Patient out-of-pocket spending in cranial neurosurgery: single-institution analysis of 6569 consecutive cases and literature review.
Yoon S; Mooney MA; Bohl MA; Sheehy JP; Nakaji P; Little AS; Lawton MT
Neurosurg Focus; 2018 May; 44(5):E6. PubMed ID: 29712524
[TBL] [Abstract][Full Text] [Related]
16. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.
Gleason PP; Starner CI; Gunderson BW; Schafer JA; Sarran HS
J Manag Care Pharm; 2009 Oct; 15(8):648-58. PubMed ID: 19803554
[TBL] [Abstract][Full Text] [Related]
17. Trends in high deductible health plan enrolment and spending among commercially insured members with and without chronic conditions: a Natural Experiment for Translation in Diabetes (NEXT-D2) Study.
Garabedian LF; Zhang F; LeCates R; Wallace J; Ross-Degnan D; Wharam JF
BMJ Open; 2021 Sep; 11(9):e044198. PubMed ID: 34518242
[TBL] [Abstract][Full Text] [Related]
18. How Have Patient Out-of-pocket Costs for Common Outpatient Orthopaedic Foot and Ankle Surgical Procedures Changed Over Time? A Retrospective Study From 2010 to 2020.
Goldfarb SI; Xu AL; Gupta A; Mun F; Durand WM; Gonzalez TA; Aiyer AA
Clin Orthop Relat Res; 2024 Feb; 482(2):313-322. PubMed ID: 37498201
[TBL] [Abstract][Full Text] [Related]
19. Cost Transparency in Neurosurgery: A Single-Institution Analysis of Patient Out-of-Pocket Spending in 13 673 Consecutive Neurosurgery Cases.
Mooney MA; Yoon S; Cole T; Sheehy JP; Bohl MA; Barranco FD; Nakaji P; Little AS; Lawton MT
Neurosurgery; 2019 Jun; 84(6):1280-1289. PubMed ID: 29767766
[TBL] [Abstract][Full Text] [Related]
20. Effect of Out-of-Pocket Costs on Subsequent Mammography Screening.
Tran L; Chetlen AL; Leslie DL; Segel JE
J Am Coll Radiol; 2022 Jan; 19(1 Pt A):24-34. PubMed ID: 34748732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
